The protein methyltransferase SET and MYND domain-containing protein 2 (SMYD2) acts as a histone lysine methyltransferase and has been acknowledged as a potential oncogene in various cancer categories, such as lung adenocarcinoma, gastric cancer 3, 4. The gene discussed is SMYD2; the disease is lung adenocarcinoma.